The International Zendal Awards objetive is to boost, spread and reward knowledge and research in the field of biotechnology to a global level.

Zendal’s mission is to bring about improvement to the conditions of life through the research and development of medicines and vaccines focused on the prevention of illnesses, as much in humans as in animals.

With this aim the Group will hold the International Zendal Awards to boost, spread and reward knowledge and research in the field of biotechnology to a global level.

In light of the developments from the SARS-CoV-2 pandemia, a new scenario is considered, where innovation and entrepreneurship can provide added value to meet the present challenges we face. That is why in this edition, on an exceptional basis, a special mention will be added for new initiatives towards finding solutions in the fight against the coronavirus.

InnovationSocial TransformationKnowledge TransferBiotechnology ResearchHealthcare

A commitment to excellence in research, development and innovation within the field of healthcare.

1. Tribute Award

María A. Blasco, Director of the National Cancer Research Center (CNIO) and head of the Telomeres and Telomerase group

María Blasco has spent a lifetime dedicated to cancer research.

Since 2011, she has directed the National Cancer Research Center (CNIO) in Spain, under whose direction she has created the CNIO’s Office for Women in Science, with the aim of promoting the presence of women in research and science. She was the first scientist woman in the world to be awarded the Josef Steiner Prize for cancer research. She has also been awarded the King Jaime I Prize, the EMBO Women in Science Awar, the Körber European Science Award from Germany, the Gold Medal from the European Molecular Biology Organization (EMBO), as well as the National Biology Prize Santiago Ramón y Cajal, among others.

Blasco is vice president of the Severo Ochoa and María de Maeztu Alliance of Centers (SOMMa) and has received three Honoris Causa doctorates in Spain: Carlos III University of Madrid (2014), Alicante University (2017) and Murcia University (2018). Maria Blasco has also been the editor of different scientific journals such as Cancer Research and the Journal of Cell Biology, and a member of several Scientific Advisory Councils in Spain and abroad. In 2020, Blasco has been named a member of the Royal Board of the Prado Museum, Madrid.

The Awards consist of:

  • Commemorative sculpture
  • Accredited Diploma

2. Human Healthcare Award

Singular Center for Research in Biological Chemistry and Molecular Materials (CIQUS)

The objective of the Ciqus project is to obtain a candidate vaccine against SARS-COV-2 that can reach the phase of clinical trials. This project is based on an own innovative proprietary methodology developed in the laboratory, which allows the generation of vaccine antigens quickly and at a low cost, which provides obvious benefits.

The Award consists of

  • 15,000 euros, that should be re-invested in the winning project
  • Accredited Diploma

3. Animal Healthcare Award

NEIKER Mycobacteria Group

The winning project has a marked innovative character by allowing better diagnosis and control of animal diseases, while changing the paradigm of the ineffectiveness of inactivated (killed) mycobacterial vaccines, showing their safety and efficacy. This opens the door to re-evaluate vaccination from the perspective of the new concept of learned immunity (trained immunity) to reduce general mortality in the first years of life and, in general, to strengthen the immune system. It is currently the only project in which a vaccine against paratuberculosis has been tested in cattle under field conditions and over a long period. The study has served to epidemiologically confirm the prediction of the theory of innate immunity learned in a domestic species other than humans.

The Award consists of

  • 15,000 euros, that should be re-invested in the winning project
  • Accredited Diploma

Juan José Badiola Díez, Professor of animal health and Director of the Center for Encephalopathies and Emerging Communicable Diseases of the University of Zaragoza

María Jesús Lamas, Director of the Spanish Agency for Medicines and Health Products

María Jaureguízar Redondo, Managing Director of the Vet+I foundation, a Spanish Technological Platform for Animal Health

Carlos Martín Montañés, Professor of Microbiology, Preventive Medicine and Public Health

Miguel Ángel Llamas, Doctor in Biochemistry and Molecular Biology, and CEO of the Empireo company, dedicated to molecular diagnostics

Jelle Thole, founder of the scientific leadership team of the TuBerculosis Vaccine Initiative (TBVI), a Netherlands-based non-profit foundation that supports the development of new tuberculosis vaccines

Esteban Rodríguez, CEO of Biofabri (Zendal Group)

Andrés Fernández, CEO of the Zendal Group

Awards Ceremony

Fundación Barrié, Vigo
Thursday, 18 November 2021
19:30 h

For any additional information: